Surgical Outcomes of Human Immunodeficiency Virus–positive Patients Undergoing Lumbar Degenerative Surgery

Abstract

Objective: The objective of this study was to determine the postoperative complications and quality outcomes of the human immunodeficiency virus (HIV)-positive patients undergoing surgical management for lumbar degenerative disease (LDD).Methods: This study identified patients with who underwent surgery for LDD between 2007 and 2016. Patients were stratified based on whether they were HIV positive at the time of surgery. Multivariate regression was utilized to reduce the confounding of baseline covariates. Patients who underwent 3 or more levels of surgical correction were under the age of 18 years, or those with any prior history of trauma or tumor were excluded from this study. Baseline comorbidities, postoperative complication rates, and reoperation rates were determined.Results: A total of 120,167 patients underwent primary lumbar degenerative surgery, of which 309 (0.26%) were HIV positive. In multivariate regression analysis, the HIV-positive cohort was more likely to be readmitted at 30 days [odds ratio (OR) = 1.9, 95% confidence interval (CI): 1.2-2.8], 60 days (OR = 1.7, 95% CI: 1.2-2.5), and 90 days (OR = 1.5, 95% CI: 1.0-2.2). The HIVpositive cohort was also more likely to experience any postoperative complication (OR = 1.7, 95% CI: 1.2-2.3). Of the major drivers identified, HIV-positive patients had significantly greater odds of cerebrovascular disease and postoperative neurological complications (OR = 3.8, 95% CI: 1.8-6.9) and acute kidney injury (OR = 3.4, 95% CI: 1.3-7.1). Costs of index hospitalization were not significantly different between the 2 cohorts